Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype
Alvar G.N. Agustí, Lisa D Edwards, Stephen I. Rennard et al. · PLoS ONE · 2012
BACKGROUND: Because chronic obstructive pulmonary disease (COPD) is a heterogeneous condition, the identification of specific clinical phenotypes is key to developing more effective therapies. To explore if the persistence of systemic inflammation is associated with poor clinical outcomes in COPD we assessed patients recruited to the well-characterized ECLIPSE cohort (NCT00292552). METHODS AND FINDINGS: Six inflammatory biomarkers in peripheral blood (white blood cells (WBC) count and CRP, IL-6, IL-8, fibrinogen and TNF-α levels) were quantified in 1,755 COPD patients, 297 smokers with normal spirometry and 202 non-smoker controls that were followed-up for three years. We found that, at baseline, 30% of COPD patients did not show evidence of systemic inflammation whereas 16% had persistent systemic inflammation. Even though pulmonary abnormalities were similar in these two groups, persistently inflamed patients during follow-up had significantly increased all-cause mortality (13% vs. 2%, p<0.001) and exacerbation frequency (1.5 (1.5) vs. 0.9 (1.1) per year, p<0.001) compared to non-inflamed ones. As a descriptive study our results show associations but do not prove causality. Besides this, the inflammatory response is complex and we studied only a limited panel of biomarkers, albeit they are those investigated by the majority of previous studies and are often and easily measured in clinical practice. CONCLUSIONS: Overall, these results identify a novel systemic inflammatory COPD phenotype that may be the target of specific research and treatment.
Cited by 848 works. doi:10.1371/journal.pone.0037483 Open-access PDF
Authors
- Alvar G.N. Agustí
- Lisa D Edwards
- Stephen I. Rennard
- William MacNee
- Ruth Tal‐Singer
- Bruce E. Miller
- Jørgen Vestbo
- David A. Lomas
- Peter M.A. Calverley
- Emiel F.�M. Wouters
- Courtney C. Crim
- Julie Yates
- Edwin K. Silverman
- Harvey O. Coxson
- Per Sigvald Bakke
- Ruth J. Mayer
- Bartolomé R. Celli
References
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
- Research confuses me: what is the difference between case-control and cohort studies in quantitative research?
- Standardization of Spirometry, 1994 Update. American Thoracic Society
- ATS Statement: Guidelines for the Six-Minute Walk Test
- Lung volumes and forced ventilatory flows
- Standardization of Spirometry — 1987 Update
- Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
- The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
- Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary